EP Edge™ Journal Watch: AVANT GUARD Trial, PFA as First-Line Therapy for Persistent AF: Half the Story

Podcast: EP Edge Journal Watch: Cardiac Electrophysiology Research · Niraj Sharma MD FACC FHRS: Cardiac Electrophysiology & Cardiology

Opublikowano: 2026-05-04

In this special HRS 2026 edition of EP Edge™ Journal Watch, Dr. Niraj Sharma takes a deep, clinically focused look at the AVANT GUARD trial, published in The New England Journal of Medicine, evaluating pulsed field ablation as initial therapy for treatment-naïve persistent atrial fibrillation. AVANT GUARD delivered the headline many expected: first-line PFA reduced atrial arrhythmia recurrence and AF burden compared with antiarrhythmic drug therapy, with 12-month freedom from atrial arrhythmia of 56% versus 30%. But the story underneath is more complex. This episode examines why AVANT GUARD may influence future AF guidelines while also requiring car...